Global Ioversol Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Ioversol
- 1.1 Definition of Ioversol
- 1.2 Ioversol Segment by Type
- 1.2.1 Global Ioversol Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Ioversol 34% Injectable Solution (Optiray 160)
- 1.2.3 Ioversol 51% Injectable Solution (Optiray 240)
- 1.2.4 Ioversol 64% Injectable Solution (Optiray 300)
- 1.2.5 Ioversol 68% Injectable Solution (Optiray 320)
- 1.2.6 Ioversol 74% Injectable Solution (Optiray 350)
- 1.3 Ioversol Segment by Applications
- 1.3.1 Global Ioversol Consumption Comparison by Applications (2014-2025)
- 1.3.2 X-ray
- 1.3.3 CT Scan
- 1.3.4 Brain Disorders
- 1.3.5 Blood Vessel Disorders
- 1.3.6 Heart Disorders
- 1.3.7 Others
- 1.4 Global Ioversol Overall Market
- 1.4.1 Global Ioversol Revenue (2014-2025)
- 1.4.2 Global Ioversol Production (2014-2025)
- 1.4.3 North America Ioversol Status and Prospect (2014-2025)
- 1.4.4 Europe Ioversol Status and Prospect (2014-2025)
- 1.4.5 China Ioversol Status and Prospect (2014-2025)
- 1.4.6 Japan Ioversol Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Ioversol Status and Prospect (2014-2025)
- 1.4.8 India Ioversol Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Ioversol
- 2.3 Manufacturing Process Analysis of Ioversol
- 2.4 Industry Chain Structure of Ioversol
3 Development and Manufacturing Plants Analysis of Ioversol
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Ioversol Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Ioversol
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Ioversol Production and Capacity Analysis
- 4.2 Ioversol Revenue Analysis
- 4.3 Ioversol Price Analysis
- 4.4 Market Concentration Degree
5 Ioversol Regional Market Analysis
- 5.1 Ioversol Production by Regions
- 5.1.1 Global Ioversol Production by Regions
- 5.1.2 Global Ioversol Revenue by Regions
- 5.2 Ioversol Consumption by Regions
- 5.3 North America Ioversol Market Analysis
- 5.3.1 North America Ioversol Production
- 5.3.2 North America Ioversol Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Ioversol Import and Export
- 5.4 Europe Ioversol Market Analysis
- 5.4.1 Europe Ioversol Production
- 5.4.2 Europe Ioversol Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Ioversol Import and Export
- 5.5 China Ioversol Market Analysis
- 5.5.1 China Ioversol Production
- 5.5.2 China Ioversol Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Ioversol Import and Export
- 5.6 Japan Ioversol Market Analysis
- 5.6.1 Japan Ioversol Production
- 5.6.2 Japan Ioversol Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Ioversol Import and Export
- 5.7 Southeast Asia Ioversol Market Analysis
- 5.7.1 Southeast Asia Ioversol Production
- 5.7.2 Southeast Asia Ioversol Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Ioversol Import and Export
- 5.8 India Ioversol Market Analysis
- 5.8.1 India Ioversol Production
- 5.8.2 India Ioversol Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Ioversol Import and Export
6 Ioversol Segment Market Analysis (by Type)
- 6.1 Global Ioversol Production by Type
- 6.2 Global Ioversol Revenue by Type
- 6.3 Ioversol Price by Type
7 Ioversol Segment Market Analysis (by Application)
- 7.1 Global Ioversol Consumption by Application
- 7.2 Global Ioversol Consumption Market Share by Application (2014-2019)
8 Ioversol Major Manufacturers Analysis
- 8.1 Liebel-Flarsheim Company LLC
- 8.1.1 Liebel-Flarsheim Company LLC Ioversol Production Sites and Area Served
- 8.1.2 Liebel-Flarsheim Company LLC Product Introduction, Application and Specification
- 8.1.3 Liebel-Flarsheim Company LLC Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Guerbet
- 8.2.1 Guerbet Ioversol Production Sites and Area Served
- 8.2.2 Guerbet Product Introduction, Application and Specification
- 8.2.3 Guerbet Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Jiangsu Hengrui Medicine Co
- 8.3.1 Jiangsu Hengrui Medicine Co Ioversol Production Sites and Area Served
- 8.3.2 Jiangsu Hengrui Medicine Co Product Introduction, Application and Specification
- 8.3.3 Jiangsu Hengrui Medicine Co Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Mallinckrodt Pharmaceuticals
- 8.4.1 Mallinckrodt Pharmaceuticals Ioversol Production Sites and Area Served
- 8.4.2 Mallinckrodt Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Mallinckrodt Pharmaceuticals Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Ultraject
- 8.5.1 Ultraject Ioversol Production Sites and Area Served
- 8.5.2 Ultraject Product Introduction, Application and Specification
- 8.5.3 Ultraject Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 China Resources Pharmaceutical (Shanghai) Co
- 8.6.1 China Resources Pharmaceutical (Shanghai) Co Ioversol Production Sites and Area Served
- 8.6.2 China Resources Pharmaceutical (Shanghai) Co Product Introduction, Application and Specification
- 8.6.3 China Resources Pharmaceutical (Shanghai) Co Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 HB Ocean
- 8.7.1 HB Ocean Ioversol Production Sites and Area Served
- 8.7.2 HB Ocean Product Introduction, Application and Specification
- 8.7.3 HB Ocean Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Novalek Pharmaceuticals Pvt. Ltd
- 8.8.1 Novalek Pharmaceuticals Pvt. Ltd Ioversol Production Sites and Area Served
- 8.8.2 Novalek Pharmaceuticals Pvt. Ltd Product Introduction, Application and Specification
- 8.8.3 Novalek Pharmaceuticals Pvt. Ltd Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Stellence Pharmscience Pvt. Ltd
- 8.9.1 Stellence Pharmscience Pvt. Ltd Ioversol Production Sites and Area Served
- 8.9.2 Stellence Pharmscience Pvt. Ltd Product Introduction, Application and Specification
- 8.9.3 Stellence Pharmscience Pvt. Ltd Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 A.S. Joshi & Company
- 8.10.1 A.S. Joshi & Company Ioversol Production Sites and Area Served
- 8.10.2 A.S. Joshi & Company Product Introduction, Application and Specification
- 8.10.3 A.S. Joshi & Company Ioversol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Ioversol Market
- 9.1 Global Ioversol Market Trend Analysis
- 9.1.1 Global Ioversol Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Ioversol Regional Market Trend
- 9.2.1 North America Ioversol Forecast 2019-2025
- 9.2.2 Europe Ioversol Forecast 2019-2025
- 9.2.3 China Ioversol Forecast 2019-2025
- 9.2.4 Japan Ioversol Forecast 2019-2025
- 9.2.5 Southeast Asia Ioversol Forecast 2019-2025
- 9.2.6 India Ioversol Forecast 2019-2025
- 9.3 Ioversol Market Trend (Product Type)
- 9.4 Ioversol Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Ioversol Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
The global Ioversol market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ioversol volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ioversol market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ioversol in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ioversol manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Segment by Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others